Go to the list of all blogs
Abhoy Sarkar's Avatar
published in Blogs
Feb 16, 2026
Apollo Global Management (APO) Earnings Preview: Q4 Expectations Highlight Growth Trajectory

Apollo Global Management (APO) Earnings Preview: Q4 Expectations Highlight Growth Trajectory

Key Takeaways

  • Analysts expect Q4 2025 adjusted EPS of $2.04, down roughly 8% year-over-year, with revenue forecasted at $1.2 billion, up 25% from the prior year.

  • Total assets under management (AUM) projected around $934 billion, reflecting strong inflows and active origination.

  • Fee-related earnings remain a focus following a record $652 million in Q3 2025, up 23% YoY.

  • Apollo has beaten EPS estimates in three of the last four quarters, averaging an 8.6% surprise.

  • Key metrics to watch include management fees, spread-related earnings, and updates to the 2026 growth outlook.

Earnings Context

Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion. Investors are particularly focused on fee-related earnings and private credit strategies, as Apollo navigates a “higher-for-longer” interest rate environment. Performance in private credit, retirement services, and other alternatives will provide a barometer of execution in a consolidating asset management industry and inform valuation multiples for the sector.

Q4 2025 Expectations

Consensus estimates call for adjusted EPS of $2.04, down about 8% YoY, with revenue expected to rise 25% to $1.2 billion. Total AUM is projected at roughly $934 billion, up from $908 billion at the end of Q3, supported by strong inflows and market appreciation.

In Q3 2025, Apollo delivered adjusted EPS of $2.17, beating estimates by 14%. Fee-related earnings reached $652 million, up 23% YoY, with management fees increasing 22%. Investors will monitor continued strength in fee-generating AUM ($685 billion in Q3) and spread-related earnings from credit deployments. The company previously guided for 15–20% growth in fee-related earnings for 2025, with potential updates for full-year 2026.

Market Sentiment

Heading into the report, investor sentiment is cautiously optimistic. Apollo has delivered three EPS beats in the last four quarters, with average post-earnings price moves ranging from 0.5% to 5%. Positive surprises tend to generate upside, supported by the firm’s strong AUM trajectory. Key risks include higher expenses offsetting inflows or weaker-than-expected performance fees. Preliminary Q4 investment income estimates of $325 million suggest stability, but fee and spread-related earnings will remain the focal point.

Forward Outlook and Key Factors

Investors should watch for updated guidance on fee-related earnings growth and spread income, particularly across Apollo’s $723 billion credit AUM as of Q3 2025. Continued inflows into private credit and retirement services will be crucial, as the firm targets surpassing $1 trillion in AUM amid AI-driven infrastructure demand and supportive fiscal conditions.

Analyst forecasts for Q1 2026 call for EPS of $2.13 (up 17% YoY), with full-year 2026 growth expected around 15%. Key considerations include cost trends, margin expansion from scale, and deployment pace in a potentially easing rate environment. Competitive dynamics, including peer M&A activity and regulatory shifts in private markets, could influence performance. Apollo’s focus on perpetual capital strategies positions the firm for durable revenue streams, but successful origination, capital deployment, and client retention will be critical for sustaining growth.

Tickeron AI trading bot

Disclaimers and Limitations

Related Ticker: APO

Momentum Indicator for APO turns positive, indicating new upward trend

APO saw its Momentum Indicator move above the 0 level on July 31, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for APO just turned positive on July 15, 2026. Looking at past instances where APO's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

APO moved above its 50-day moving average on July 31, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for APO crossed bullishly above the 50-day moving average on August 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where APO advanced for three days, in of 358 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 315 cases where APO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for APO moved below the 200-day moving average on July 28, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

APO broke above its upper Bollinger Band on August 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. APO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.175) is normal, around the industry mean (3.569). P/E Ratio (49.327) is within average values for comparable stocks, (27.541). Projected Growth (PEG Ratio) (0.635) is also within normal values, averaging (1.269). APO has a moderately low Dividend Yield (0.015) as compared to the industry average of (0.086). P/S Ratio (2.295) is also within normal values, averaging (17.979).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Ares Capital Corp (NASDAQ:ARCC), WisdomTree (NYSE:WT), AMTD IDEA Group (NYSE:AMTD).

Industry description

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

Market Cap

The average market capitalization across the Investment Managers Industry is 9.98B. The market cap for tickers in the group ranges from 57 to 179.79B. BLK holds the highest valuation in this group at 179.79B. The lowest valued company is RSERF at 57.

High and low price notable news

The average weekly price growth across all stocks in the Investment Managers Industry was 3%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 2%. CWD experienced the highest price growth at 46%, while BENF experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the Investment Managers Industry was 11%. For the same stocks of the Industry, the average monthly volume growth was 78% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 33
P/E Growth Rating: 57
Price Growth Rating: 54
SMR Rating: 74
Profit Risk Rating: 77
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
APO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of global alternative asset management services

Industry InvestmentManagers

Profile
Details
Industry
Investment Managers
Address
9 West 57th Street
Phone
+1 212 515-3200
Employees
2540
Web
https://www.apollo.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.